
Accelerator mass spectrometry techniques
Accelerator Mass Spectrometry (AMS) is an ultra-sensitive analytical technique based on the use of an ion accelerator as a powerful mass spectrometer.
Showing 861 - 880 of 1085 results
Accelerator Mass Spectrometry (AMS) is an ultra-sensitive analytical technique based on the use of an ion accelerator as a powerful mass spectrometer.
This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.
Below lists some useful programs for data reduction, search matching, analysis and structure visualisation of diffraction data.
The Imaging and Medical beamline (IMBL) is a flagship beamline of the Australian Synchrotron built with considerable support from the NHMRC. It is one of only a few of its type, and delivers the world’s widest synchrotron x-ray ‘beam’.
The complex engineering of scientific instruments is explored in this 'behind the scenes' look at the installation of frontends for two new beamlines at the Australian Synchrotron.
Excellent radiolabelling facilities and the operation of OPAL, a world-class multi-purpose nuclear reactor, enable ANSTO to produce a large range of radioisotopes for Australian researchers in both radiopharmaceutical and environmental areas.
Researchers use Kitaev theoretical model to explain unusual phenomenon in two-dimensional material.
Three ANSTO staff members were involved in a chemical spill this morning when approx 250mL of sodium hydroxide was released from a pipe.
ANSTO sets out the following terms and conditions relating to users who access our facilities for the purpose of research.
An international team led by ANSTO has been awarded a prestigious program grant from the Foundation for Australia-Japan Studies.
Latest information on the scheduled supply of our nuclear medicine production.
Four international authorities will deliver plenary addresses virtually at the 15th International Conference on Accelerator Mass Spectrometry (AMS15) , which will be held online from 15-19 November.
ANSTO’s Innovation Precinct has been highlighted in the Greater Sydney Commission’s South District Plan.
Modified component of green tea promises potential neuroblastoma treatment.